Doxycycline responding illnesses in returning travellers with undifferentiated non-malaria fever: a european multicenter prospective cohort study.
Daniel Camprubí-FerrerJosé Antonio OteoEmmanuel BottieauBlaise GentonLeire Balerdi-SarasolaAránzazu PortilloLudovico CobuccioSteven Van Den BrouckeSonia SantibáñezDániel CadarNatalia RodriguezAlex Almuedo-RieraCarme SubiràValérie d'AcremontMiguel J MartinezMontserrat RoldánJessica Navero-CastillejosMarjan Van EsbroeckJose MuñozPublished in: Journal of travel medicine (2022)
Although DRI are responsible for 30% of undifferentiated NMF cases in travellers, those are seldom recognized during the first clinical encounter. Empirical treatment with doxycycline should be considered in returning travellers with undifferentiated fever and negative tests for malaria and dengue, particularly when presenting severe illness, predictive factors for rickettsiosis or no features of dengue.